HIC is a pediatric and women’s health focused venture capital impact fund. The firm’s thesis targets therapeutic, medical technology, and care service solutions that address the unmet medical needs of these patient populations. HIC’s leadership and partnership philosophies are that of an active ally, which brings over 150 years of thought leadership and execution excellence in: pediatric patient care, clinical research outcomes, commercializing innovation, and providing investors with meaning alpha. HIC is committed to supporting clinical growth, corporate maturation, market adoption, and tangible improvement in patient care quality and outcomes- attributes that are consistent with best-in-class healthcare solutions.

To reinforce HIC’s patient centric impact investing and ESG strategy, the firm established The Health Innovation Capital Foundation, a 501c3 not-for-profit that donates an expected 10% of the General Partner’s Carry Interest, or 2% of the firm’s overall return performance, back to select centers of pediatric healthcare excellence. The objective is for each institution to leverage this donation to propel the evolution of early-stage pediatric, maternal/fetal health, perinatal, and postpartum medical research and innovation.

A core pillar of HIC’s operating model and investment thesis: to achieve an exceptional fund performance and a sustainable upper quartile net return on investment, the firm partners with entrepreneurs and business models that are dedicated to commercializing innovation that improves the quality of care and outcomes for pediatric and maternal health patients globally.